The store will not work correctly when cookies are disabled.
1-(cyclopropylmethyl)-N-(4-methoxyphenyl)-1H-imidazo[4,5-c]pyridin-6-amine
ID: ALA4792380
PubChem CID: 162671468
Max Phase: Preclinical
Molecular Formula: C17H18N4O
Molecular Weight: 294.36
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(Nc2cc3c(cn2)ncn3CC2CC2)cc1
Standard InChI: InChI=1S/C17H18N4O/c1-22-14-6-4-13(5-7-14)20-17-8-16-15(9-18-17)19-11-21(16)10-12-2-3-12/h4-9,11-12H,2-3,10H2,1H3,(H,18,20)
Standard InChI Key: SODIMCQABALFOL-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
18.2451 -2.0553 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.2439 -2.8749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9520 -3.2838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9502 -1.6465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6588 -2.0517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6591 -2.8703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4377 -3.1231 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.9187 -2.4606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4373 -1.7986 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.6905 -3.9002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4898 -4.0699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5359 -3.2829 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.8285 -2.8737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8337 -2.0567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1271 -1.6476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4181 -2.0557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4201 -2.8771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1272 -3.2825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0948 -4.6136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2644 -3.8142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7102 -1.6475 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.7098 -0.8303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
10 11 1 0
2 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
19 11 1 0
20 19 1 0
11 20 1 0
16 21 1 0
21 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 294.36 | Molecular Weight (Monoisotopic): 294.1481 | AlogP: 3.59 | #Rotatable Bonds: 5 |
Polar Surface Area: 51.97 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.98 | CX LogP: 2.92 | CX LogD: 2.91 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.78 | Np Likeness Score: -1.17 |
References
1. Lewis A,Beresford A,Chambers MS,Clark G,Hartley DC,Hirst KL,Higashino M,Kawahadara S,Nakanishi M,Saito T,Imagawa A,Habashita H,Maidment S,Macleod AM,Owens AP,Rae A,Rouse C,Wishart G. (2020) Discovery of ONO-8590580: A novel, potent and selective GABA α negative allosteric modulator for the treatment of cognitive disorders., 30 (22): [PMID:32898695] [10.1016/j.bmcl.2020.127536] |